Professor Sir Munir Pirmohamed, Chair of the Commission on Human Medicines – who endorsed the approval of Evusheld – mentioned that, for those eligible, the “recommended dosage is 300mg of Evusheld”.
Professor Pirmohamed added: “But a higher dose of 600mg may be more appropriate for some COVID-19 variants.”
Clinical trials have demonstrated that Evusheld was found to reduce the risk of developing symptomatic Covid by 77 percent.
Symptoms of Covid
The Centers for Disease Control and Prevention (CDC) listed the symptoms of Covid, which includes:
- Fever or chills
- Cough
- Shortness of breath or difficulty breathing
- Fatigue
- Muscle or body aches
- Headache
- New loss of taste or smell
- Sore throat
- Congestion or runny nose
- Nausea or vomiting
- Diarrhoea.